Bayer AG (BAYN)-Medical Equipment-Deals and Alliances Profile

Bayer AG (BAYN)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME40270D
  • |
  • Pages: 85
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women's healthcare, oncology, hematology, ophthalmology, infection and other indications. The company product portfolio includes prescription products, specialty therapeutics, animal health care products, diagnostic imaging equipment, nonprescription (over-the-counter-OTC) products, seeds, crop protection solutions, nonagricultural pest control solutions, and high-tech polymer materials. Bayer markets its healthcare and crop protection products principally through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, the US, and other markets such as Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG (BAYN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 6

Bayer AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 7

Bayer AG, Medical Equipment Deals By Type, 2011 to YTD 2017 8

Bayer AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 9

Bayer AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 10

Bayer AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 11

Bayer AG, Medical Equipment, Deal Details 13

Partnerships 13

Bayer Enters into Licensing Agreement with DelSiTech 13

ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology 13

Icagen Enters into Agreement with Bayer 14

Bayer Enters into Co-Development Agreement with Leica Biosystems 15

T2 Biosystems Enters into R&D Agreement with Bayer 16

Genedata Enters into Co-Development Agreement with Bayer Pharma 16

Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 17

Ventana Extends Co-Development Agreement With Bayer Pharma 18

Sysmex Inostics Enters Into Co-Development Agreement With Bayer HealthCare 19

Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion System 20

Bayer HealthCare Enters Into Agreement With Medsintez 20

Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology 21

Bayer HealthCare Enters Into Co-Marketing Agreement With Radimetrics For eXposure 22

Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device 22

Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 23

Bayer Vital Signs Agreement With Vital Images 24

Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare 25

Debt Offering 26

Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 26

Bayer Raises USD1.4 Billion in Public Offering of 2.375% Hybrid Bonds Due 2075 27

Bayer Prices 1.25% Bonds Due 2023 for USD623.5 Million 28

Bayer Raises USD2.38 Billion in Public Offering of 3% Bonds Due 2075 28

Bayer Raises USD2 Billion in Public Offering of 3.75% Bonds Due 2074 30

Bayer Raises USD677.3 Million in Public Offering of Notes Due 2016 31

Bayer Raises USD1.02 Billion in Public Offering of 1.125% Notes Due 2018 32

Bayer Raises USD1.02 Billion in Public Offering of 1.875% Bonds Due 2021 33

Bayer Completes Public Offering Of Notes Due 2019 For US$102 Million 34

Bayer Completes Public Offering Of Notes Due 2016 For US$259 Million 35

Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million 36

Asset Transactions 37

Bayer May Sell Radiology Business 37

Panasonic Healthcare Acquires Diabetes Care Business from Bayer for USD1.15 Billion 37

Boston Scientific Acquires Vascular Catheter Business of Bayer for USD415 Million 38

Polymer Technology Systems Acquires A1CNow From Bayer Diabetes Care 39

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 40

Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare 41

Acquisition 42

Bayer May Acquire Sirtex Medical 42

Bayer Completes Acquisition Of 96.4% Stake In Conceptus For US$1.1 Billion 43

Bayer HealthCare To Acquire Radimetrics, Healthcare Software Maker 44

MEDRAD Completes Acquisition Of Pathway Medical Technologies For US$125 Million 45

Bayer AG-Key Competitors 47

Key Employees 48

Locations And Subsidiaries 51

Head Office 51

Other Locations & Subsidiaries 51

Recent Developments 62

Strategy And Business Planning 62

Sep 20, 2016: Bayer sets ambitious growth and earnings aspirations 62

Financial Announcements 64

Apr 27, 2017: Strong start to the year for Bayer 64

Apr 26, 2016: Bayer Announces Interim report for the first quarter of 2016 67

Corporate Communications 69

Jun 05, 2017: Bayer Expands Oncology Organization with Two New Leadership Team Appointments 69

May 02, 2017: Bayer Appoints Bhavesh Ashar to Lead U.S. Oncology Business 70

Apr 27, 2017: Supervisory Board of Bayer extends service contract of CFO Johannes Dietsch to the end of May 2018 71

Jan 17, 2017: Dr. Carsten Brunn to Lead Bayer Pharmaceuticals Business in the Americas Region 72

Apr 25, 2016: 2016 Otto Bayer Award goes to Professor Dr. Dirk Trauner 73

Mar 23, 2016: Dr. Michael Preuss to be new head of Communications at Bayer 74

Feb 24, 2016: Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG 75

Government and Public Interest 76

Feb 22, 2017: Another record year for Bayer - good progress with the acquisition of Monsanto 76

Product News 79

Feb 29, 2016: FDA takes additional action to better understand safety of Essure, inform patients of potential risks 79

Other Significant Developments 81

Jul 27, 2016: Bayer raises sales and earnings 81

Appendix 85

Methodology 85

About GlobalData 85

Contact Us 85

Disclaimer 85

List of Figures

Bayer AG, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Bayer AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Bayer AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Bayer AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Bayer AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 7

Bayer AG, Medical Equipment, Deals by Type, 2011 to YTD 2017 8

Bayer AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 9

Bayer AG, Medical Equipment, Deals by Market, 2011 to YTD 2017 10

List of Tables

Bayer AG, Medical Equipment, Key Facts, 2016 1

Bayer AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Bayer AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 7

Bayer AG, Medical Equipment Deals By Type, 2011 to YTD 2017 8

Bayer AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 9

Bayer AG, Deals By Market, 2011 to YTD 2017 10

Bayer AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 11

Bayer Enters into Licensing Agreement with DelSiTech 13

ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology 13

Icagen Enters into Agreement with Bayer 14

Bayer Enters into Co-Development Agreement with Leica Biosystems 15

T2 Biosystems Enters into R&D Agreement with Bayer 16

Genedata Enters into Co-Development Agreement with Bayer Pharma 16

Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 17

Ventana Extends Co-Development Agreement With Bayer Pharma 18

Sysmex Inostics Enters Into Co-Development Agreement With Bayer HealthCare 19

Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion System 20

Bayer HealthCare Enters Into Agreement With Medsintez 20

Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology 21

Bayer HealthCare Enters Into Co-Marketing Agreement With Radimetrics For eXposure 22

Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device 22

Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 23

Bayer Vital Signs Agreement With Vital Images 24

Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare 25

Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 26

Bayer Raises USD1.4 Billion in Public Offering of 2.375% Hybrid Bonds Due 2075 27

Bayer Prices 1.25% Bonds Due 2023 for USD623.5 Million 28

Bayer Raises USD2.38 Billion in Public Offering of 3% Bonds Due 2075 28

Bayer Raises USD2 Billion in Public Offering of 3.75% Bonds Due 2074 30

Bayer Raises USD677.3 Million in Public Offering of Notes Due 2016 31

Bayer Raises USD1.02 Billion in Public Offering of 1.125% Notes Due 2018 32

Bayer Raises USD1.02 Billion in Public Offering of 1.875% Bonds Due 2021 33

Bayer Completes Public Offering Of Notes Due 2019 For US$102 Million 34

Bayer Completes Public Offering Of Notes Due 2016 For US$259 Million 35

Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million 36

Bayer May Sell Radiology Business 37

Panasonic Healthcare Acquires Diabetes Care Business from Bayer for USD1.15 Billion 37

Boston Scientific Acquires Vascular Catheter Business of Bayer for USD415 Million 38

Polymer Technology Systems Acquires A1CNow From Bayer Diabetes Care 39

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 40

Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare 41

Bayer May Acquire Sirtex Medical 42

Bayer Completes Acquisition Of 96.4% Stake In Conceptus For US$1.1 Billion 43

Bayer HealthCare To Acquire Radimetrics, Healthcare Software Maker 44

MEDRAD Completes Acquisition Of Pathway Medical Technologies For US$125 Million 45

Bayer AG, Key Competitors 47

Bayer AG, Key Employees 48

Bayer AG, Subsidiaries 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Bayer AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16020
Site License
USD 500 INR 32040
Corporate User License
USD 750 INR 48060

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com